Nasopharyngeal Cancer
Nasopharyngeal cancer originates in the upper throat behind the nose, an area rich in lymphatic tissue.
It’s more prevalent in certain regions and linked to Epstein-Barr virus (EBV).
This cancer often presents late due to vague early symptoms like ear fullness or nasal blockage.
Overview And Clinical Background
It develops in the nasopharynx and often spreads to lymph nodes early.
Viral, genetic, and dietary factors contribute to risk.
Symptoms, Signs And Presentation
Symptoms resemble chronic sinusitis, delaying diagnosis.
Neck swelling is often the first sign.
Diagnosis Methods And Investigations
Imaging And Laboratory Tests
Nasopharyngoscopy and biopsy confirm diagnosis, supported by imaging and EBV tests.
Treatment Options And Surgical Techniques
Treatment focuses on radiotherapy, often with chemotherapy.
Surgery is rarely needed.
Recovery, Risks And Prognosis
Most patients respond well to radiotherapy.
Prognosis improves with early-stage diagnosis.
Why Choose Us
CureU Healthcare offers precision radiotherapy, ENT oncology teams, and EBV-based diagnostic support for nasopharyngeal cancers.
Conclusion
Nasopharyngeal cancer, though rare, is treatable with early detection and integrated radiation-based management.
